Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The ORION-4 team at the Joint Annual Collaborators meeting in May 2022


ORION-4 has been designed and is coordinated by Oxford University’s Clinical Trial Service Unit (CTSU) (part of the Nuffield Department of Population Health), one of the world’s leading centres for this type of research. 

The study is co-sponsored by the University of Oxford and Novartis Pharmaceutical Corporation and is designed and run in collaboration with researchers at the TIMI Study Group at Brigham and Women’s Hospital in Boston, USA. 

See Our Team for more information about the people leading and running the study at CTSU.